Grundläggande statistik
| CIK | 1413797 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to OxySure Therapeutics, Inc.
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
| April 18, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-54137 OXYSURE THERAPEUTICS, INC. (Exact name of registrant as specified |
|
| April 12, 2016 |
CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION OXYSURE THERAPEUTICS, INC. Exhibit 3.2 CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF OXYSURE THERAPEUTICS, INC. OxySure Therapeutics, Inc. (the “Company”), organized and existing under and by virtue of the Delaware General Corporation Law, does hereby certify: FIRST: That the Board of Directors (the “Board”) of the Company adopted a proposed amendment to the Company’s Articles of Incorporation to increase the |
|
| April 12, 2016 |
CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION OXYSURE THERAPEUTICS, INC. EX-3.1 2 f8k041216ex3ioxysure.htm AS CORRECTED CERTIFICATE OF AMENDMENT, FILED APRIL 6, 2016, TO THE COMPANY'S ARTICLES OF INCORPORATION Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF OXYSURE THERAPEUTICS, INC. OxySure Therapeutics, Inc. (the “Company”), organized and existing under and by virtue of the Delaware General Corporation Law, does hereby certify: FIRST: That th |
|
| April 12, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 12, 2016 OxySure Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54137 71-0960725 (State or other jurisdiction of incorporation or organi |
|
| March 30, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54137 CUSIP NUMBER 69208T101 (Check One): Form 10-K ? Form 20-F o Form 1l-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR o For Year Ended: December 31, 2015 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Trans |
|
| February 26, 2016 |
OxySure Therapeutics PRELIMINARY PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive |
|
| January 28, 2016 |
Exhibit 99.1 January 26, 2016 Senator John Cornyn 5001 Spring Valley Road Suite 1125 E Dallas, TX 75244 Dear Senator Cornyn: Texans and Others Have Been Harmed by Unscrupulous Traders We write on behalf of OxySure Therapeutics, Inc. and numerous Texans and others who have been severely harmed by greedy, unscrupulous broker dealers and their clients. We are seeking your help to refer these matters |
|
| January 28, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 28, 2016 OxySure Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54137 71-0960725 (State or other jurisdiction of incorporation or orga |
|
| December 11, 2015 |
OXYS / OxySure Therapeutics, Inc. / Black Mountain Equities, Inc. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to Rules 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2 (AMENDMENT NO. )* OxySure Therapeutics, Inc. (Name of Issuer) Common Stock, $0.0004 par value (Title of Class of Securities) 69208T 101 (CUSIP Number) December 4 |
|
| December 11, 2015 |
OXYS / OxySure Therapeutics, Inc. / GEMINI MASTER FUND LTD - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to Rules 13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to Rule 13d-2 (AMENDMENT NO. )* OxySure Therapeutics, Inc. (Name of Issuer) Common Stock, $0.0004 par value (Title of Class of Securities) 69208T 101 (CUSIP Number) December 1 |
|
| December 2, 2015 |
CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF OXYSURE SYSTEMS, INC. Exhibit 3.1 State of Delaware Secretary of State Division of Corporations Delivered 10:47 AM 11/30/2015 FILED 10:47 AM 11/30/2015 SR 201511024666 - File Number 3753195 CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF OXYSURE SYSTEMS, INC. OxySure Systems, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of De |
|
| December 2, 2015 |
OxySure Systems, Inc. (OXYS) Completes Name Change to OxySure Therapeutics, Inc. EX-99.1 4 f8k12215ex99ioxys.htm Exhibit 99.1 OxySure Systems, Inc. (OXYS) Completes Name Change to OxySure Therapeutics, Inc. Frisco, Texas, December 2, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology and other innovative medical sol |
|
| December 2, 2015 |
8-K 1 f8k12215oxys.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 2, 2015 OxySure Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54137 71-0960725 (State or other |
|
| November 16, 2015 |
OxySure Therapeutics QUARTERLY REPORT (Quarterly Report) 10-Q 1 f10q0915oxysure.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-54137 OXYSURE S |
|
| November 9, 2015 |
OxySure (OXYS) Files Lawsuit – Seeks Millions in Damages EX-99.1 2 f8k110915ex99ioxysure.htm PRESS RELEASE Exhibit 99.1 OxySure (OXYS) Files Lawsuit – Seeks Millions in Damages FRISCO, TX - (Marketwired – November 3, 2015) – OxySure Systems, Inc. (OTCQB: OXYS), (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology and other innovative me |
|
| November 9, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 9, 2015 OxySure Systems, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54137 71-0960725 (State or other jurisdiction of incorporation or organizat |
|
| November 9, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 9, 2015 OxySure Systems, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54137 71-0960725 (State or other jurisdiction of incorporation or organizat |
|
| November 9, 2015 |
OxySure (OXYS) Board Approves Name Change to OxySure Therapeutics, Inc. Exhibit 99.1 OxySure (OXYS) Board Approves Name Change to OxySure Therapeutics, Inc. Frisco, Texas, November 9, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology and other innovative medical solutions, today announced that its Board of |
|
| September 17, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 15, 2015 OxySure Systems, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54137 71-0960725 (State or other jurisdiction of incorporation or organiz |
|
| August 19, 2015 |
10-Q 1 f10q0615oxysure.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-54137 OXYSURE SYSTEM |
|
| August 18, 2015 |
OxySure Therapeutics SCHEDULE 14A DEF 14A 1 def14a0815oxysuresyste.htm SCHEDULE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission On |
|
| August 17, 2015 |
OxySure Therapeutics NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54137 CUSIP NUMBER 69208T101 (Check One): Form 10-K ? Form 20-F ? Form 1l-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR ? For Period Ended: June 30, 2015 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transit |
|
| August 6, 2015 |
OxySure Therapeutics PRELIMINARY PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive |
|
| July 17, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 17, 2015 (July 14, 2015) OxySure Systems, Inc. |
|
| July 8, 2015 |
EX-99.7 8 f8k063015a1ex99viioxysuresy.htm SECURITIES PURCHASE AGREEMENT Exhibit 99.7 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 30, 2015, by and between Oxysure Systems, Inc., a Delaware corporation, with headquarters located at 10880 John W. Elliott Drive, Suite 600, Frisco, TX 75033 (the “Company”), and Union Capital LLC., a New York Limi |
|
| July 8, 2015 |
Exhibit 99.3 Oxysure Systems, Inc. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES D CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE Delaware GENERAL CORPORATION LAW The undersigned, Julian T. Ross, Chief Executive Officer, does hereby certify that: 1. He is the Chief Executive Officer of Oxysure Systems, Inc., a Delaware corporation (the “Corporation”). 2. T |
|
| July 8, 2015 |
OxySure Systems (OXYS) Closes $3 Million Institutional Financing Exhibit 99.1 OxySure Systems (OXYS) Closes $3 Million Institutional Financing Frisco, Texas, July 7, 2015 ? OxySure Systems, Inc. (OTCQB: OXYS) (?OxySure,? or the ?Company?), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its ?oxygen from powder? technology today announced that the Company has closed a $3 million institutional financing transaction. Pursuan |
|
| July 8, 2015 |
8-K/A 1 f8k063015a1oxysuresyste.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 8, 2015 (June 30, 2015) OxySure Systems, Inc. (Exact name of registrant as specified in its charter) Delaware 00 |
|
| July 8, 2015 |
Exhibit 99.2 Oxysure Systems, Inc. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES C CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE Delaware GENERAL CORPORATION LAW The undersigned, Julian T. Ross, Chief Executive Officer, does hereby certify that: 1. He is the Chief Executive Officer of Oxysure Systems, Inc., a Delaware corporation (the ?Corporation?). 2. T |
|
| July 8, 2015 |
Exhibit 99.5 STOCK PURCHASE WARRANT NEITHER THIS WARRANT NOR ANY SECURITIES ON EXERCISE HEREOF HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF REGISTRATION UNDER SUCH ACT AND APPLICABLE LAWS, OR THE AVAILABILITY OF AN EXEMPTION FROM SUCH REGISTRATION, OR AN OP |
|
| July 8, 2015 |
EX-99.4 5 f8k063015a1ex99ivoxysuresy.htm CERTIFICATE OF DESIGNATION OF PREFERENCES Exhibit 99.4 Oxysure Systems, Inc. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES E CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE Delaware GENERAL CORPORATION LAW The undersigned, Julian T. Ross, Chief Executive Officer, does hereby certify that: 1. He is the Chief Executive |
|
| July 8, 2015 |
EX-99.6 7 f8k063015a1ex99vioxysuresy.htm SECURITIES PURCHASE AGREEMENT Exhibit 99.6 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 30, 2015, by and between Oxysure Systems, Inc., a Delaware corporation, with headquarters located at 10880 John W. Elliott Drive, Suite 600, Frisco, TX 75033 (the “Company”), and Adar Bays LLC., a Florida Limited Li |
|
| July 7, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 7, 2015 (June 30, 2015) OxySure Systems, Inc. |
|
| July 7, 2015 |
OxySure Systems (OXYS) Closes $3 Million Institutional Financing Exhibit 99.1 OxySure Systems (OXYS) Closes $3 Million Institutional Financing Frisco, Texas, July 7, 2015 ? OxySure Systems, Inc. (OTCQB: OXYS) (?OxySure,? or the ?Company?), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its ?oxygen from powder? technology today announced that the Company has closed a $3 million institutional financing transaction. Pursuan |
|
| May 18, 2015 |
10-Q 1 f10q0315oxysuresystems.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-54137 OXYSUR |
|
| May 15, 2015 |
OxySure Therapeutics FORM NT-10Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54137 CUSIP NUMBER 69208T101 (Check One): Form 10-K o Form 20-F o Form 1l-K o Form 10-Q ? Form 10-D o Form N-SAR o Form N-CSR o For Period Ended: March 31, 2015 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transi |
|
| April 13, 2015 |
Exhibit 99.1 Julian Ross From: JONES, VICKI Sent: Monday, April 6, 2015 4:08 PM To: Julian Ross Subject: OxySure Board Seat Categories: Red Category Hi Julian, I wanted to inform you that my workload continues to expand due to merger integration work and another highly sensitive special project I have been asked to lead. Due to these demands I must be realistic about my inability to invest time in |
|
| April 13, 2015 |
OxySure Therapeutics CURRENT REPORT (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 6, 2015 (April 10, 2015) OxySure Systems, Inc. |
|
| March 31, 2015 |
RENEWED AND EXTENDED PROMISSORY NOTE Exhibit 10.2.4 RENEWED AND EXTENDED PROMISSORY NOTE $148,000.00 Frisco, Texas May 22, 2014 FOR VALUE RECEIVED, OXYSURE SYSTEMS, INCORPORATED, a Delaware corporation (hereinafter called "Maker"), promises to pay to the order of FRISCO ECONOMIC DEVELOPMENT CORPORATION, a Texas corporation (hereinafter sometimes called "Holder"), at 6801 Gaylord Parkway, Ste. 400, Frisco, TX 75034, or at such place a |
|
| March 31, 2015 |
Exhibit 10.26 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of December , 2014, between Oxysure Systems, Inc., a Delaware corporation (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a ?Purchaser? and collectively, the ?Purchasers?). WHEREAS, subject to the terms and |
|
| March 31, 2015 |
Exhibit 99.2 |
|
| March 31, 2015 |
Exhibit 99.1 OXYSURE (OXYS) REPORTS FOURTH QUARTER AND FULL-YEAR 2014 RESULTS Conference Call at 9:00 am ET on March 31, 2015 Frisco, Texas, March 31, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), today announced financial and operating results for the fourth quarter and year ended December 31, 2014. Fiscal Year 2014 Highlights: ● Revenues were $2.4 million, up 35%, led |
|
| March 31, 2015 |
COMMON STOCK PURCHASE WARRANT OXYSURE SYSTEMS, INC. EX-10.27 6 f10k2014ex10xxviioxysure.htm FORM OF WARRANT ISSUED TO SECURITIES PURCHASE AGREEMENT Exhibit 10.27 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECU |
|
| March 31, 2015 |
EXCLUSIVE DISTRIBUTION AGREEMENT EX-10.29 7 f10k2014ex10xxixoxysure.htm EXCLUSIVE DISTRIBUTION AGREEMENT Exhibit 10.29 EXCLUSIVE DISTRIBUTION AGREEMENT This Distribution Agreement (together with its related exhibits, the “Agreement”) is made and executed this , (the “Effective Date”) by and between OXYSURE® SYSTEMS, INC. (“OxySure” or “OxySure®”), a Delaware, USA corporation with its primary place of business located at 10880 Joh |
|
| March 31, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 31, 2015 (March 31, 2015) OXYSURE SYSTEMS, INC. |
|
| March 31, 2015 |
Exhibit 10.23.1 Oxysure Systems, Inc. AMENDED CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES B CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE Delaware GENERAL CORPORATION LAW The undersigned, Julian T. Ross, Chief Executive Officer, does hereby certify that: 1. He is the Chief Executive Officer of Oxysure Systems, Inc., a Delaware corporation (the ?Corporat |
|
| March 31, 2015 |
Exhibit 10.2.3 SECOND AMENDED AND RESTATED PERFORMANCE AGREEMENT Between FRISCO ECONOMIC DEVELOPMENT CORPORATION And OXYSURE SYSTEMS, INCORPORATED This Second Amended and Restated Performance Agreement (the ?Agreement?) is made and entered into by and between the Frisco Economic Development Corporation, (the ?FEDC?), a Texas corporation organized and existing under Chapter 501 and 504 of the Texas |
|
| March 31, 2015 |
10-K 1 f10k2014oxysuresystem.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2014 Commission File No. 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 71-0960725 (State of Incor |
|
| January 20, 2015 |
8-K 1 f8k011215oxysure.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 16, 2015 (January 12, 2015) OxySure Systems, Inc. (Exact name of registrant as specified in its chapter) Delaware 000-54137 71-0960725 ( |
|
| January 20, 2015 |
OxySure (OXYS) Re-Appoints Julian T. Ross as Chairman and CEO Exhibit 99.1 OxySure (OXYS) Re-Appoints Julian T. Ross as Chairman and CEO FRISCO, Texas, January 16, 2015, (MarketWired) - OxySure Systems, Inc. (OXYS: OTCQB) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that the Company has re-appointed Julian T. Ross as its Chairman and |
|
| January 20, 2015 |
Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (hereinafter referred to as the "Agreement") is made and entered into as of the 1st day of January, 2015 (“Effective Date”), by and between OXYSURE SYSTEMS, INC., a corporation duly organized and existing pursuant to the laws of the state of Delaware, (hereinafter referred to as "OSI" or the “Company”), and JULIAN T. ROSS (hereinafter ref |
|
| January 6, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 6, 2015 (December 29, 2014) OxySure Systems, Inc. |
|
| January 6, 2015 |
OxySure (OXYS) Announces $1.575 Million Institutional Financing Exhibit 99.1 OxySure (OXYS) Announces $1.575 Million Institutional Financing Frisco, Texas, January 6, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced that the Company has signed agreements for $1.575 million in equity financing with |
|
| November 26, 2014 |
Termination of a Material Definitive Agreement 8-K 1 f8k112114oxysure.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 26, 2014 (November 21, 2014) OxySure Systems, Inc. (Exact name of registrant as specified in its chapter) Delaware 000-54137 71-0960725 (Stat |
|
| November 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as sp |
|
| October 24, 2014 |
Exhibit 99.1 OxySure (OXYS) Announces Merger with Estill Medical Technologies Business Combination Creates Emerging Medical Device Platform Company FRISCO, Texas, October 22, 2014, (MarketWired) – OxySure Systems, Inc. (OTCQB: OXYS) the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its FDA-cleared “oxygen from powder” technology, along with Estill Medical Tech |
|
| October 24, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 24, 2014 (October 21, 2014) OXYSURE SYSTEMS, INC. |
|
| October 24, 2014 |
Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER BY AND AMONG OXYSURE SYSTEMS, INC., OSI ACQUISITION, INC., ESTILL MEDICAL TECHNOLOGIES, INC., THE SHAREHOLDERS IDENTIFIED HEREIN, and THE SECURITYHOLDERS’ REPRESENTATIVE IDENTIFIED HEREIN Dated as of October 21, 2014 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 1.1 Defined Terms 1 ARTICLE II THE MERGER; CLOSING 1 2.1 Merger and Effective |
|
| October 24, 2014 |
Exhibit 99.2 . |
|
| September 19, 2014 |
OxySure (OXYS) Welcomes Clark Hood as Vice President, Resuscitation Sales Worldwide Exhibit 99.1 OxySure (OXYS) Welcomes Clark Hood as Vice President, Resuscitation Sales Worldwide FRISCO, Texas, September 18, 2014, (MarketWired) — OxySure(R) Systems, Inc. (OXYS: OTCQB) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that the Company has appointed Clark E. Ho |
|
| September 19, 2014 |
Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (hereinafter referred to as the "Agreement") is made and entered into as of the 17th day of September, 2014 (“Agreement Date”), by and between OXYSURE SYSTEMS, INC., a corporation duly organized and existing pursuant to the laws of the state of Delaware, (the hereinafter referred to as "OSI" or the “Company”), and Clark Hood (hereinafter |
|
| September 19, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 19, 2014 (September 17, 2014) OxySure Systems, Inc. |
|
| September 10, 2014 |
OxySure (OXYS) Announces $2.4 Million Contract Exhibit 99.1 OxySure (OXYS) Announces $2.4 Million Contract FRISCO, Texas, September 9, 2014, (MarketWired) - OxySure(R) Systems, Inc. (OXYS: OTCQB) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that the Company has signed a distribution contract with Ajad Medical to be the |
|
| September 10, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 10, 2014 (September 4, 2014) OxySure Systems, Inc. |
|
| August 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as specifi |
|
| May 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as specif |
|
| April 15, 2014 |
Exhibit 10.42.1 CONTRACT This contract (hereinafter referred to as the “Contract”) is entered into on this 25th day of March , 2013 (the “Effective Date”) by OxySure Systems, Inc., located at 10880 John W. Elliott Drive, Suite 600, Frisco, Texas 75033 (hereinafter referred to as “OXYS”); and PPAviation Corp., located at 62 Stutzman Road, Bowmansville, NY 14026-1046, herein referred to as “PPA” (OX |
|
| April 15, 2014 |
[SIGNATURES TO FOLLOW ON NEXT PAGE] Exhibit 10.3.6 December 31, 2013 Julian T. Ross Chairman & CEO OxySure Systems, Inc. 10880 John W. Elliott Road Suite 600 Frisco, TX 75033 Re: Letter Agreement (this "Agreement") between SINACOLA COMMERCIAL PROPERTIES, LTD., a Texas limited partnership ("Landlord"), and OXYSURE SYSTEMS, INC., a Delaware corporation ("Tenant") Dear Julian: Landlord and Tenant have agreed to exchange certain conside |
|
| April 15, 2014 |
Exhibit 10.39 OXYSURE SYSTEMS, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES B CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Julian T. Ross, Chief Executive Officer, does hereby certify that: 1. He is the Chief Executive Officer of Oxysure Systems, Inc., a Delaware corporation (the “Corporation”). 2. |
|
| April 15, 2014 |
Exhibit 10.11.6 Tue 2/18/2014 6:24 AM Julian, The Settlement Date of December 31, 2013 referenced in both the Third Payment Moratorium & Settlement Agreement dated July 29, 2013 and the Subscription Agreement dated November 1, 2013, each of which was executed by Oxysure Systems, Inc. and VenCore Solutions LLC, is hereby extended to April 1, 2014. Jim Johnson VenCore Solutions LLC dba Vencore Capit |
|
| April 15, 2014 |
Exhibit 10.38 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the “Agreement”) is between OxySure Systems, Inc., having its principal place of business at 10880 John West Elliot Drive, Suite 600 Frisco, TX 75033 (hereinafter referred to as “Company”); and Wall Street Buy Sell Hold Inc., having its principal place of business at 135 Glenwood Rd., Glenwood Landing, NY 11547 (hereinafter referred to |
|
| April 15, 2014 |
Exhibit 10.40 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December , 2013, between Oxysure Systems, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and |
|
| April 15, 2014 |
TEAMING AGREEMENT --- NUMBER 2 --- BY AND BETWEEN OXYSURE SYSTEMS, INC. PPAVIATION CORP. Exhibit 10.42.2 TEAMING AGREEMENT - NUMBER 2 - BY AND BETWEEN OXYSURE SYSTEMS, INC. AND PPAVIATION CORP. SECTION A. Basis of the Agreement B. Definitions C. Purpose and Formation of Teaming Arrangement D. Term, Termination, and Breach of the Agreement E. Parties Resources F. Marketing Effort G. Ownership of Technology/Right in Invention Patents, Copyrights H. Confidentiality and Non-Disclosure I. |
|
| April 15, 2014 |
TEAMING AGREEMENT BY AND BETWEEN OXYSURE SYSTEMS, INC. PPAVIATION CORP. Exhibit 10.42 TEAMING AGREEMENT BY AND BETWEEN OXYSURE SYSTEMS, INC. AND PPAVIATION CORP. SECTION A. Basis of the Agreement B. Definitions C. Purpose and Formation of Teaming Arrangement D. Term, Termination, and Breach of the Agreement E. Parties Resources F. Marketing Effort G. Ownership of Technology/Right in Invention Patents, Copyrights H. Confidentiality and Non-Disclosure I. Warranties J. S |
|
| April 15, 2014 |
Exhibit 10.1.11 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (hereinafter referred to as the "Agreement") is made and entered into as of the 15th day of January, 2010 (“Effective Date”), by and between OXYSURE SYSTEMS, INC., a corporation duly organized and existing pursuant to the laws of the state of Delaware, (hereinafter referred to as "OSI" or the “Company”), and JULIAN T. ROSS (hereinafter |
|
| April 15, 2014 |
THIRD PAYMENT MORATORIUM SETTLEMENT AGREEMENT Exhibit 10.11.5 THIRD PAYMENT MORATORIUM & SETTLEMENT AGREEMENT This THIRD PAYMENT MORATORIUM & SETTLEMENT AGREEMENT (the “Agreement”) is made as of July 29, 2013 by and between VENCORE SOLUTIONS LLC, a Delaware limited liability company (“Vencore”), and OXYSURE® SYSTEMS, INC., a Delaware corporation (“Oxysure”). RECITALS A. Master Lease Agreement Number 6906 (the “MLA”) and Lease Schedule Numbers |
|
| April 15, 2014 |
Exhibit 14.1.1 To All Employees: The nature and scope of the Company's operations place a significant trust in individual employees. Since its founding, the Company has always operated with the highest ethical standards. The Company rewards the contribution of its employees by providing challenging employment, pleasant working facilities, and a commitment to long term job security. The importance |
|
| April 15, 2014 |
Exhibit 10.42.1 CONTRACT This contract (hereinafter referred to as the “Contract”) is entered into on this 25th day of March , 2013 (the “Effective Date”) by OxySure Systems, Inc., located at 10880 John W. Elliott Drive, Suite 600, Frisco, Texas 75033 (hereinafter referred to as “OXYS”); and PPAviation Corp., located at 62 Stutzman Road, Bowmansville, NY 14026-1046, herein referred to as “PPA” (OX |
|
| April 15, 2014 |
TEAMING AGREEMENT BY AND BETWEEN OXYSURE SYSTEMS, INC. PPAVIATION CORP. Exhibit 10.42 TEAMING AGREEMENT BY AND BETWEEN OXYSURE SYSTEMS, INC. AND PPAVIATION CORP. SECTION A. Basis of the Agreement B. Definitions C. Purpose and Formation of Teaming Arrangement D. Term, Termination, and Breach of the Agreement E. Parties Resources F. Marketing Effort G. Ownership of Technology/Right in Invention Patents, Copyrights H. Confidentiality and Non-Disclosure I. Warranties J. S |
|
| April 15, 2014 |
MODIFICATION OF AGREEMENT (FIFTH MODIFICATION) Exhibit 10.1.10 MODIFICATION OF AGREEMENT (FIFTH MODIFICATION) WHEREAS, OxySure Systems, Inc. (“OxySure”) and Julian T. Ross (“Ross”) (OxySure and Ross jointly, the “Parties”) entered into that certain Employment Agreement (“Agreement”) dated January 15, 2009, as amended, for the second time on June 23, 2009, and as further amended for the third time on January 15, 2010; and as further amended for |
|
| April 15, 2014 |
TEAMING AGREEMENT --- NUMBER 2 --- BY AND BETWEEN OXYSURE SYSTEMS, INC. PPAVIATION CORP. Exhibit 10.42.2 TEAMING AGREEMENT - NUMBER 2 - BY AND BETWEEN OXYSURE SYSTEMS, INC. AND PPAVIATION CORP. SECTION A. Basis of the Agreement B. Definitions C. Purpose and Formation of Teaming Arrangement D. Term, Termination, and Breach of the Agreement E. Parties Resources F. Marketing Effort G. Ownership of Technology/Right in Invention Patents, Copyrights H. Confidentiality and Non-Disclosure I. |
|
| April 15, 2014 |
Exhibit 10.41 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGIS |
|
| April 15, 2014 |
THIRD AMENDMENT TO OFFICE LEASE AGREEMENT Exhibit 10.3.5 THIRD AMENDMENT TO OFFICE LEASE AGREEMENT This Third Amendment to Office Lease Agreement (this "Amendment") is executed with an effective date as of October 14, 2012, between SINACOLA COMMERCIAL PROPERTIES, LTD., a Texas limited partnership ("Landlord"), and OXYSURE SYSTEMS, INC., a Delaware corporation ("Tenant"). Capitalized terms used herein but not defined shall be given the mea |
|
| April 15, 2014 |
Exhibit 10.39 OXYSURE SYSTEMS, INC. CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES B CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Julian T. Ross, Chief Executive Officer, does hereby certify that: 1. He is the Chief Executive Officer of Oxysure Systems, Inc., a Delaware corporation (the ?Corporation?). 2. |
|
| April 15, 2014 |
THIRD PAYMENT MORATORIUM SETTLEMENT AGREEMENT Exhibit 10.11.5 THIRD PAYMENT MORATORIUM & SETTLEMENT AGREEMENT This THIRD PAYMENT MORATORIUM & SETTLEMENT AGREEMENT (the “Agreement”) is made as of July 29, 2013 by and between VENCORE SOLUTIONS LLC, a Delaware limited liability company (“Vencore”), and OXYSURE® SYSTEMS, INC., a Delaware corporation (“Oxysure”). RECITALS A. Master Lease Agreement Number 6906 (the “MLA”) and Lease Schedule Numbers |
|
| April 15, 2014 |
Exhibit 10.1.11 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (hereinafter referred to as the "Agreement") is made and entered into as of the 15th day of January, 2010 (“Effective Date”), by and between OXYSURE SYSTEMS, INC., a corporation duly organized and existing pursuant to the laws of the state of Delaware, (hereinafter referred to as "OSI" or the “Company”), and JULIAN T. ROSS (hereinafter |
|
| April 15, 2014 |
10-K/A 1 f10k2013oxysure.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No.1 to FORM 10-K/A ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2013 Commission File No. 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 71-0960725 |
|
| April 15, 2014 |
Exhibit 14.1.1 To All Employees: The nature and scope of the Company's operations place a significant trust in individual employees. Since its founding, the Company has always operated with the highest ethical standards. The Company rewards the contribution of its employees by providing challenging employment, pleasant working facilities, and a commitment to long term job security. The importance |
|
| April 15, 2014 |
MODIFICATION OF AGREEMENT (FIFTH MODIFICATION) Exhibit 10.1.10 MODIFICATION OF AGREEMENT (FIFTH MODIFICATION) WHEREAS, OxySure Systems, Inc. (“OxySure”) and Julian T. Ross (“Ross”) (OxySure and Ross jointly, the “Parties”) entered into that certain Employment Agreement (“Agreement”) dated January 15, 2009, as amended, for the second time on June 23, 2009, and as further amended for the third time on January 15, 2010; and as further amended for |
|
| April 15, 2014 |
THIRD AMENDMENT TO OFFICE LEASE AGREEMENT Exhibit 10.3.5 THIRD AMENDMENT TO OFFICE LEASE AGREEMENT This Third Amendment to Office Lease Agreement (this "Amendment") is executed with an effective date as of October 14, 2012, between SINACOLA COMMERCIAL PROPERTIES, LTD., a Texas limited partnership ("Landlord"), and OXYSURE SYSTEMS, INC., a Delaware corporation ("Tenant"). Capitalized terms used herein but not defined shall be given the mea |
|
| April 15, 2014 |
Exhibit 10.40 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December , 2013, between Oxysure Systems, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and |
|
| April 15, 2014 |
Exhibit 10.11.6 Tue 2/18/2014 6:24 AM Julian, The Settlement Date of December 31, 2013 referenced in both the Third Payment Moratorium & Settlement Agreement dated July 29, 2013 and the Subscription Agreement dated November 1, 2013, each of which was executed by Oxysure Systems, Inc. and VenCore Solutions LLC, is hereby extended to April 1, 2014. Jim Johnson VenCore Solutions LLC dba Vencore Capit |
|
| April 15, 2014 |
EX-10.41 11 f10k2013ex10xlioxysure.htm ALPHA CAPITAL ANSTALT ET AL, FORM OF WARRANT ISSUED PURSUANT TO SECURITIES PURCHASE AGREEMENT Exhibit 10.41 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITI |
|
| April 15, 2014 |
[SIGNATURES TO FOLLOW ON NEXT PAGE] Exhibit 10.3.6 December 31, 2013 Julian T. Ross Chairman & CEO OxySure Systems, Inc. 10880 John W. Elliott Road Suite 600 Frisco, TX 75033 Re: Letter Agreement (this "Agreement") between SINACOLA COMMERCIAL PROPERTIES, LTD., a Texas limited partnership ("Landlord"), and OXYSURE SYSTEMS, INC., a Delaware corporation ("Tenant") Dear Julian: Landlord and Tenant have agreed to exchange certain conside |
|
| April 15, 2014 |
Exhibit 10.38 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the “Agreement”) is between OxySure Systems, Inc., having its principal place of business at 10880 John West Elliot Drive, Suite 600 Frisco, TX 75033 (hereinafter referred to as “Company”); and Wall Street Buy Sell Hold Inc., having its principal place of business at 135 Glenwood Rd., Glenwood Landing, NY 11547 (hereinafter referred to |
|
| April 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K 10-K 1 f10k2013oxysure.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2013 Commission File No. 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 71-0960725 (State of Incorporati |
|
| March 31, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54137 CUSIP NUMBER 69208T101 (Check One): Form 10-K þ Form 20-F o Form 1l-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR o For Year Ended: December 31, 2013 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Trans |
|
| March 31, 2014 |
OxySure Systems (OXYS) Announces Investor Update on Annual Report Exhibit 99.1 OxySure Systems (OXYS) Announces Investor Update on Annual Report Frisco, Texas, March 31, 2014 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today provided an investor update regarding the Company’s expected reporting timeline for its annu |
|
| March 31, 2014 |
Financial Statements and Exhibits, Other Events 8-K 1 f8k033114oxysure.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report March 31, 2014 OxySure Systems, Inc. (Exact name of registrant as specified in its charter) Delaware 000-54137 71-0960725 (State or other jurisdiction of incorporation (Commission File |
|
| March 21, 2014 |
Exhibit 99.1 OxySure Systems is Saddened to Announce the Death of Don Reed, Director Frisco, Texas, March 21, 2014 – OxySure Systems, Inc. (“OxySure,” or the “Company”) is saddened to announce the death of Don Reed, a member of the OxySure Board of Directors. Mr. Reed died peacefully at home in Argyle, Texas on March 5th, 2014. “This is obviously a great loss not only for our Company but for our c |
|
| March 21, 2014 |
Regulation FD Disclosure, Financial Statements and Exhibits - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 5, 2014 (March 21, 2014) OxySure Systems, Inc. |
|
| March 10, 2014 |
Financial Statements and Exhibits, Other Events - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report March 10, 2014 OxySure Systems, Inc. |
|
| March 10, 2014 |
Exhibit 99.1 |
|
| March 3, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report March 3, 2014 OxySure Systems, Inc. |
|
| March 3, 2014 |
Exhibit 99.1 OxySure CEO Provides Shareholders With a "State of the Union" Communication Emphasis on Clear Business and Financial Model, Significant Intellectual Property, Progress with Global Distribution Footprint With Billion Dollar Market Potential FRISCO, TX - (Marketwired - March 3, 2014) – OxySure Systems, Inc. (OTCQB: OXYS), (“OxySure,” or the “Company”), the medical device innovator of li |
|
| February 18, 2014 |
OXYS / OxySure Therapeutics, Inc. / Sinacola Commercial Properties, Ltd. - SC 13G Passive Investment SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 OxySure Systems, Inc. (Name of Issuer) Common Stock, par value $0.0004 per share (Title of Class of Securities) 69208T101 (CUSIP Number) February 14, 2014 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan |
|
| January 29, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 29, 2014 (January 23, 2014) OxySure Systems, Inc. |
|
| January 29, 2014 |
OxySure Systems (OXYS) Improves Balance Sheet by Reducing Debt by Nearly $1 Million Exhibit 99.1 OxySure Systems (OXYS) Improves Balance Sheet by Reducing Debt by Nearly $1 Million FRISCO, Texas, January 27, 2014, (MarketWired) - OxySure(R) Systems, Inc. (OXYS: OTCQB) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that the Company has removed approximately $ |
|
| January 2, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 2, 2014 (December 26, 2013) OxySure Systems, Inc. |
|
| January 2, 2014 |
OxySure Systems (OXYS) Closes $750,000 Institutional Private Placement Exhibit 99.1 OxySure Systems (OXYS) Closes $750,000 Institutional Private Placement FRISCO, Texas, January 2, 2014 - OxySure(R) Systems, Inc. (OXYS: OTCQB) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that it has closed a $750,000 private placement with accredited instituti |
|
| December 20, 2013 |
Financial Statements and Exhibits, Other Events - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report December 19, 2013 OxySure Systems, Inc. |
|
| December 20, 2013 |
OxySure Systems (OXYS) Expands to Hong Kong and Macau Exhibit 99.1 OxySure Systems (OXYS) Expands to Hong Kong and Macau FRISCO, Texas, December 18, 2013, 2013 (MarketWired) - OxySure(R) Systems, Inc. (OXYS: OTCQB) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that Pacific Medical Systems, Ltd. has signed an agreement to be the |
|
| November 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as sp |
|
| August 13, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as specifi |
|
| August 6, 2013 |
Entry into a Material Definitive Agreement - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 6, 2013 (August 2, 2013) OxySure Systems, Inc. |
|
| August 5, 2013 |
EX-16.1 August 1, 2013 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Re: OxySure Systems, Inc. Ladies and Gentlemen: We have read the statements made by OxySure Systems, Inc., which were provided to us and which we understand will be filed with the Securities and Exchange Commission pursuant to Item 4.01 of its Form 8-K, regarding the change in certifying accountant. We |
|
| August 5, 2013 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 5, 2013 (August 1, 2013) OxySure Systems, Inc. |
|
| June 6, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 6, 2013 (June 5, 2013) OxySure Systems, Inc. |
|
| May 15, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as specif |
|
| April 2, 2013 |
Exhibit 10.11.3 STOCK PURCHASE WARRANT NEITHER THIS WARRANT NOR ANY SECURITIES ON EXERCISE HEREOF HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF REGISTRATION UNDER SUCH ACT AND APPLICABLE LAWS, OR THE AVAILABILITY OF AN EXEMPTION FROM SUCH REGISTRATION, OR AN |
|
| April 2, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K 10-K 1 f10k2012oxysure.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2012 Commission File No. 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 71-0960725 (State of Incorporati |
|
| April 2, 2013 |
Exhibit 10.5.4 OPTIONAL CONVERSION NOTICE To: OxySure Systems, Inc. (“Obligor”) Date: December 31, 2012 The undersigned, JTR Investments, Limited ("Holder") holder of that certain convertible senior note with an outstanding amount of $1,018,656 and dated December 31,2008, as amended (“Senior Note”), and the holder of that certain subordinated convertible note in the amount of $250,000 and dated Ma |
|
| April 2, 2013 |
10-K/A 1 f10k2012oxysure.htm AMENDED ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No.1 to FORM 10-K/A ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2012 Commission File No. 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 71 |
|
| April 2, 2013 |
Exhibit 10.4.4 OPTIONAL CONVERSION NOTICE To: OxySure Systems, Inc. (“Obligor”) Date: December 31, 2012 The undersigned, Agave Resources, LLC ("Holder") holder of that certain subordinated convertible note in the amount of $750,000 and dated April 15, 2008, as amended (“First Note”) hereby irrevocably exercises the option to convert all of the Principal Amount and accrued but unpaid interest (if a |
|
| April 2, 2013 |
OXYSURE SYSTEMS, INC. INDEPENDENT CONTRACTOR AGREEMENT Exhibit 10.36 OXYSURE SYSTEMS, INC. INDEPENDENT CONTRACTOR AGREEMENT This Independent Contract Agreement (the ?Agreement?), dated October 8, 2012, between OxySure Systems, Inc., a Delaware corporation (?OxySure?) and Chris Hagerman (collectively reference to as ?you?, ?your? or ?Consultant?) shall constitute the terms and conditions under which Chris Hagerman will provide services to OxySure as an |
|
| April 2, 2013 |
Exhibit 10.22.1 CONVERSION AGREEMENT WHEREAS, OxySure Systems, Inc. (“OxySure”) and SINACOLA COMMERCIAL PROPERTIES, LTD. (“Sinacola”) (OxySure and Sinacola jointly, the “Parties”) entered into that certain Rent Satisfaction Agreement (“Agreement”) dated December10, 2009; and WHEREAS, OxySure has issued Sinacola two convertible promissory notes pursuant to the Agreement, with a face value totaling |
|
| April 2, 2013 |
MODIFICATION OF AGREEMENT (FOURTH MODIFICATION) Exhibit 10.1.8 MODIFICATION OF AGREEMENT (FOURTH MODIFICATION) WHEREAS, OxySure Systems, Inc. (?OxySure?) and Julian T. Ross (?Ross?) (OxySure and Ross jointly, the ?Parties?) entered into that certain Employment Agreement (?Agreement?) dated January 15, 2009, as amended, for the second time on June 23, 2009, and as further amended for the third time on January 15, 2010; and WHEREAS, The Parties h |
|
| April 2, 2013 |
SATISFACTION AGREEMENT FOR CITI LEASE 3, DATED DECEMBER 5, 2012* Exhibit 10.15.3 |
|
| April 2, 2013 |
SECOND PAYMENT MORATORIUM AND SETTLEMENT AGREEMENT Exhibit 10.11.2 SECOND PAYMENT MORATORIUM AND SETTLEMENT AGREEMENT THIS SECOND PAYMENT MORATORIUM AND SETTLEMENT AGREEMENT (the “Agreement”) is made as of July 9, 2012 by and between VENCORE SOLUTIONS LLC, a Delaware limited liability company (“Vencore”), and OXYSURE® SYSTEMS, INC., a Delaware corporation (“Oxysure”). RECITALS A. Master Lease Agreement Number 6906 (the “MLA”) and Lease Schedule Nu |
|
| April 2, 2013 |
Exhibit 10.11.4 STOCK PURCHASE WARRANT NEITHER THIS WARRANT NOR ANY SECURITIES ON EXERCISE HEREOF HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF REGISTRATION UNDER SUCH ACT AND APPLICABLE LAWS, OR THE AVAILABILITY OF AN EXEMPTION FROM SUCH REGISTRATION, OR AN |
|
| April 2, 2013 |
SATISFACTION AGREEMENT FOR CITI LEASES 1 AND 2, DATED JULY 19, 2012* Exhibit 10.15.2 |
|
| April 2, 2013 |
Exhibit 10.15.2 |
|
| April 2, 2013 |
Exhibit 10.4.4 OPTIONAL CONVERSION NOTICE To: OxySure Systems, Inc. (“Obligor”) Date: December 31, 2012 The undersigned, Agave Resources, LLC ("Holder") holder of that certain subordinated convertible note in the amount of $750,000 and dated April 15, 2008, as amended (“First Note”) hereby irrevocably exercises the option to convert all of the Principal Amount and accrued but unpaid interest (if a |
|
| April 2, 2013 |
Exhibit 10.19 1 2 3 4 |
|
| April 2, 2013 |
Exhibit 10.11.3 STOCK PURCHASE WARRANT NEITHER THIS WARRANT NOR ANY SECURITIES ON EXERCISE HEREOF HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF REGISTRATION UNDER SUCH ACT AND APPLICABLE LAWS, OR THE AVAILABILITY OF AN EXEMPTION FROM SUCH REGISTRATION, OR AN |
|
| April 2, 2013 |
Exhibit 10.5.4 OPTIONAL CONVERSION NOTICE To: OxySure Systems, Inc. (“Obligor”) Date: December 31, 2012 The undersigned, JTR Investments, Limited ("Holder") holder of that certain convertible senior note with an outstanding amount of $1,018,656 and dated December 31,2008, as amended (“Senior Note”), and the holder of that certain subordinated convertible note in the amount of $250,000 and dated Ma |
|
| April 2, 2013 |
Exhibit 10.37 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the “Agreement”) is between OxySure Systems, Inc., having its principal place of business at 10880 John West Elliot Drive, Suite 600 Frisco, TX 75033 (hereinafter referred to as “Company”); and Wall Street Buy Sell Hold Inc., having its principal place of business at 135 Glenwood Rd., Glenwood Landing, NY 11547 (hereinafter referred to |
|
| April 2, 2013 |
Exhibit 10.22.1 CONVERSION AGREEMENT WHEREAS, OxySure Systems, Inc. (“OxySure”) and SINACOLA COMMERCIAL PROPERTIES, LTD. (“Sinacola”) (OxySure and Sinacola jointly, the “Parties”) entered into that certain Rent Satisfaction Agreement (“Agreement”) dated December10, 2009; and WHEREAS, OxySure has issued Sinacola two convertible promissory notes pursuant to the Agreement, with a face value totaling |
|
| April 2, 2013 |
Exhibit 10.1.9 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (hereinafter referred to as the "Agreement") is made and entered into as of the 15th day of January, 2010 (?Effective Date?), by and between OXYSURE SYSTEMS, INC., a corporation duly organized and existing pursuant to the laws of the state of Delaware, (hereinafter referred to as "OSI" or the ?Company?), and JULIAN T. ROSS (hereinafter |
|
| April 2, 2013 |
SATISFACTION AGREEMENT FOR CITI LEASE 3, DATED DECEMBER 5, 2012* Exhibit 10.15.3 |
|
| April 2, 2013 |
Exhibit 10.19 1 2 3 4 |
|
| April 2, 2013 |
SECOND PAYMENT MORATORIUM AND SETTLEMENT AGREEMENT Exhibit 10.11.2 SECOND PAYMENT MORATORIUM AND SETTLEMENT AGREEMENT THIS SECOND PAYMENT MORATORIUM AND SETTLEMENT AGREEMENT (the “Agreement”) is made as of July 9, 2012 by and between VENCORE SOLUTIONS LLC, a Delaware limited liability company (“Vencore”), and OXYSURE® SYSTEMS, INC., a Delaware corporation (“Oxysure”). RECITALS A. Master Lease Agreement Number 6906 (the “MLA”) and Lease Schedule Nu |
|
| April 2, 2013 |
MODIFICATION OF AGREEMENT (FOURTH MODIFICATION) Exhibit 10.1.8 MODIFICATION OF AGREEMENT (FOURTH MODIFICATION) WHEREAS, OxySure Systems, Inc. (“OxySure”) and Julian T. Ross (“Ross”) (OxySure and Ross jointly, the “Parties”) entered into that certain Employment Agreement (“Agreement”) dated January 15, 2009, as amended, for the second time on June 23, 2009, and as further amended for the third time on January 15, 2010; and WHEREAS, The Parties h |
|
| April 2, 2013 |
OXYSURE SYSTEMS, INC. INDEPENDENT CONTRACTOR AGREEMENT Exhibit 10.36 OXYSURE SYSTEMS, INC. INDEPENDENT CONTRACTOR AGREEMENT This Independent Contract Agreement (the “Agreement”), dated October 8, 2012, between OxySure Systems, Inc., a Delaware corporation (“OxySure”) and Chris Hagerman (collectively reference to as “you”, “your” or “Consultant”) shall constitute the terms and conditions under which Chris Hagerman will provide services to OxySure as an |
|
| April 2, 2013 |
Exhibit 10.37 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the “Agreement”) is between OxySure Systems, Inc., having its principal place of business at 10880 John West Elliot Drive, Suite 600 Frisco, TX 75033 (hereinafter referred to as “Company”); and Wall Street Buy Sell Hold Inc., having its principal place of business at 135 Glenwood Rd., Glenwood Landing, NY 11547 (hereinafter referred to |
|
| April 2, 2013 |
Exhibit 10.11.4 STOCK PURCHASE WARRANT NEITHER THIS WARRANT NOR ANY SECURITIES ON EXERCISE HEREOF HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF REGISTRATION UNDER SUCH ACT AND APPLICABLE LAWS, OR THE AVAILABILITY OF AN EXEMPTION FROM SUCH REGISTRATION, OR AN |
|
| April 2, 2013 |
Exhibit 10.1.9 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (hereinafter referred to as the "Agreement") is made and entered into as of the 15th day of January, 2010 (?Effective Date?), by and between OXYSURE SYSTEMS, INC., a corporation duly organized and existing pursuant to the laws of the state of Delaware, (hereinafter referred to as "OSI" or the ?Company?), and JULIAN T. ROSS (hereinafter |
|
| April 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54137 CUSIP NUMBER 69208T101 (Check One): Form 10-K þ Form 20-F o Form 1l-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR o For Year Ended: December 31, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Trans |
|
| March 26, 2013 |
Exhibit 99.1 OxySure Systems (OXYS) Adds Jeremy M. Jones, Former Chairman & CEO of Apria Healthcare as New Independent Director FRISCO, Texas, and Irvine, California, March 26, 2013 (GLOBE NEWSWIRE) - OxySure(R) Systems, Inc. (OXYS: OTCQB) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today |
|
| March 26, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 26, 2013 OxySure Systems, Inc. |
|
| March 26, 2013 |
Exhibit 10.1 March 18, 2013 Mr. Jeremy M. Jones 19712 MacArthur Blvd, #230 Irvine, CA 92612 Dear Jerry: I am pleased to formalize our invitation for you to serve on the Board of Directors of OxySure Systems, Inc. (OTCQB: OXYS) (the “Company” or “OxySure”). We look forward to working with you and we are excited to be able to have access to your guidance and counsel, experience and expertise in the |
|
| January 3, 2013 |
Exhibit 99.1 News Release OxySure (OXYS) Affiliates Convert $2.02 Million in Notes to Common Stock at $1.50 Per Share Conversion Price represents 52% Premium to Market Frisco, Texas, January 3, 2013 – OxySure® Systems, Inc. (OTCBB:OXYS) (“OxySure,” or the “Company”), the medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today a |
|
| January 3, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 3, 2013 (December 31, 2012) OxySure Systems, Inc. |
|
| November 15, 2012 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 15, 2012 (November 14, 2012) OxySure Systems, Inc. |
|
| November 15, 2012 |
Exhibit 99.1 OxySure (OXYS) Announces 3Q 2012 Quarterly Financial Results; Outperforms on Key Metrics Hosting Investor Conference Call Frisco, Texas, November 14, 2012 – OxySure® Systems, Inc. (OTCBB:OXYS) (“OxySure,” or the “Company”), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced its results for the thi |
|
| November 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as sp |
|
| August 31, 2012 |
Unregistered Sales of Equity Securities - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 31, 2012 (August 29, 2012) OxySure Systems, Inc. |
|
| August 15, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 15, 2012 (August 14, 2012) OxySure Systems, Inc. |
|
| August 15, 2012 |
OxySure Announces 2Q 2012 Quarterly Financial Results; Posts Significant Improvement to Bottom Line Exhibit 99.1 Media Contact(s): Yves Dezawy (646) 546-5151 [email protected] www.OxySure.com OxySure Announces 2Q 2012 Quarterly Financial Results; Posts Significant Improvement to Bottom Line Frisco, Texas, August 15, 2012 – OxySure® Systems, Inc. (OTCBB:OXYS) (“OxySure,” or the “Company”), the pioneering manufacturer of life-saving easy-to-use emergency oxygen solutions with its “oxygen from powde |
|
| August 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as specifi |
|
| July 31, 2012 |
Regulation FD Disclosure - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 31, 2012 (July 26, 2012) OxySure Systems, Inc. |
|
| July 13, 2012 |
Entry into a Material Definitive Agreement - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 13, 2012 (July 9, 2012) OxySure Systems, Inc. |
|
| June 28, 2012 |
Unregistered Sales of Equity Securities - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 28, 2012 OxySure Systems, Inc. |
|
| June 14, 2012 |
OxySure Inks Distribution Agreement with Global Industrial, a Systemax Company Exhibit 99.1 OxySure Inks Distribution Agreement with Global Industrial, a Systemax Company Frisco, Texas and Port Washington, NY, June 13, 2012 – OxySure® Systems, Inc. (OTCBB: OXYS), the pioneering manufacturer of life-saving easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced a distribution agreement with Global Industrial, a Systemax (NYSE: SYX) Comp |
|
| June 14, 2012 |
Regulation FD Disclosure, Financial Statements and Exhibits - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 14, 2012 (June 13, 2012) OxySure Systems, Inc. |
|
| May 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as specif |
|
| May 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54137 CUSIP NUMBER 69208T101 (Check One): Form 10-K o Form 20-F o Form 1l-K o Form 10-Q þ Form 10-D o Form N-SAR o Form N-CSR o For Period Ended: March 31, 2012 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transi |
|
| May 4, 2012 |
Entry into a Material Definitive Agreement - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 3, 2012 OxySure Systems, Inc. |
|
| April 9, 2012 |
Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 6, 2012 OxySure Systems, Inc. |
|
| April 9, 2012 |
OxySure to Hold Conference Call to Discuss FY2011 Financial Results and Recent Developments EX-99.1 2 v308817ex99-1.htm EXHIBIT 99.1 Media Contact(s): Yves Dezawy (646) 546-5151 [email protected] www.OxySure.com OxySure to Hold Conference Call to Discuss FY2011 Financial Results and Recent Developments Frisco, Texas, April 6, 2012 – OxySure® Systems, Inc. (OTCBB:OXYS) (“OxySure,” or the “Company”), the pioneering manufacturer of lifesaving, easy-to-use emergency oxygen solutions with its |
|
| April 2, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 30, 2012 OxySure Systems, Inc. |
|
| April 2, 2012 |
Media Contact(s): Yves Dezawy (646) 546-5151 [email protected] www.OxySure.com OxySure Announces 2011 Fiscal Year Financial Results Maintains net loss of $.10 per share on 21.3% lower SG&A during IPO year Frisco, Texas, March 30, 2012 – OxySure® Systems, Inc. (OTCBB:OXYS) (“OxySure,” or the “Company”), today reported a slightly narrower net loss of $1,532,399, or $0.10 per diluted share, for fiscal |
|
| March 30, 2012 |
[SIGNATURES TO FOLLOW ON NEXT PAGE] August 15, 2011 Julian T. Ross Chairman & CEO OxySure Systems, Inc. 10880 John W. Elliott Road Suite 600 Frisco, TX 75034 Re: Letter Agreement (this "Agreement") between SINACOLA COMMERCIAL PROPERTIES, LTD., a Texas limited partnership ("Landlord"), and OXYSURE SYSTEMS, INC., a Delaware corporation ("Tenant") Dear Julian: Landlord and Tenant have agreed to exchange certain consideration for certai |
|
| March 30, 2012 |
FOURTH MODIFICATION OF AGREEMENT FOURTH MODIFICATION OF AGREEMENT WHEREAS, OxySure Systems, Inc. (“OxySure”) and JTR Investments, Ltd. (“JTR”) (OxySure and JTR jointly, the “Parties”) entered into that certain Promissory Note (“Note”) dated 3/1/08 in the principal amount of $250,000; and WHEREAS, The Parties have agreed that it is in their best interests to modify the terms of the Note. NOW, WHEREFORE, FOR GOOD AND VALUABLE CONSI |
|
| March 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2011 Commission File No. 000-54137 OXYSURE SYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 71-0960725 (State of Incorporation) (IRS Employer I.D. Number) 10880 John |
|
| March 30, 2012 |
FOURTH MODIFICATION OF AGREEMENT FOURTH MODIFICATION OF AGREEMENT WHEREAS, OxySure Systems, Inc. (“OxySure”) and Agave Resources, LLC. (“Agave”) (OxySure and Agave jointly, the “Parties”) entered into that certain Promissory Note (“Note”) dated 4/15/08 in the principal amount of $750,000; and WHEREAS, The Parties have agreed that it is in their best interests to modify the terms of the Note. NOW, WHEREFORE, FOR GOOD AND VALUABLE |
|
| March 30, 2012 |
EXHIBIT A OPTIONAL CONVERSION NOTICE To: OxySure Systems, Inc. ("Obligor") The undersigned, Afritex Medical Products (Pty) Ltd. ("Holder") of that certain Subordinated Convertible Note dated March 26, 2010 (“Note”) issued by Obligor in favor of Holder, hereby irrevocably exercises the option to convert $335,880 of the Principal Amount and accrued but unpaid interest outstanding under the Note into |
|
| March 30, 2012 |
SUPPLIER AGREEMENT This Agreement between W.W. Grainger, Inc., for and on behalf of itself, and its current and future subsidiaries, divisions and affiliates ("Grainger") with general business offices at 100 Grainger Parkway, Lake Forest, IL 60045-5201 and OxySure Systems, Inc. ("Supplier") with general business offices at Corporate Office and with a Grainger supplier number of Supplier Number TBD |
|
| March 15, 2012 |
OxySure Systems Announces Supplier Agreement with Grainger Media Contact(s): Yves Dezawy (646) 546-5151 [email protected] www.OxySure.com OxySure Systems Announces Supplier Agreement with Grainger Frisco, Texas, March 15, 2012 – OxySure® Systems, Inc. (OTCBB:OXYS) (“OxySure”), the pioneering manufacturer of life-saving easy-to-use emergency oxygen solutions with its “oxygen from powder” technology has announced the Company has entered into a Supplier Agree |
|
| March 15, 2012 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 15, 2012 OxySure Systems, Inc. |
|
| February 6, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 6, 2012 OxySure Systems, Inc. |
|
| February 2, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 2, 2012 OxySure Systems, Inc. |
|
| November 21, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-159402 OXYSURE SYSTEMS, INC. (Exact name of registrant as s |
|
| November 16, 2011 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 16, 2011 OxySure Systems, Inc. |
|
| November 14, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-159402 CUSIP NUMBER 69208T101 (Check One): Form 10-K o Form 20-F o Form 1l-K o Form 10-Q þ Form 10-D o Form N-SAR o Form N-CSR o For Period Ended: September 30, 2011 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o T |
|
| October 26, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Amendment No. 1) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-159402 OXYSURE SYSTEMS, INC. (Exact name of |
|
| October 17, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 17, 2011 OxySure Systems, Inc. |
|
| September 26, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 333-159402 OXYSURE SYSTEMS, INC. (Exact name of registrant as specif |
|
| August 19, 2011 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 15, 2011 OxySure Systems, Inc. |
|
| August 16, 2011 |
Filed Pursuant to Rule 424(b)(2) Registration No. 333-159402 PROSPECTUS 8,915,565 Shares of Common Stock OxySure? Systems, Inc. This is our initial public offering. There is no public market for our common stock. It is our intention to seek quotation of our common stock by a market maker on an over-the-counter electronic quotation system such as the OTC Bulletin Board subsequent to the date of thi |
|
| August 11, 2011 |
Julian T. Ross, President OxySure Systems, Inc. 10880 John W. Elliott Drive, Suite 600 Frisco, TX 75034 August 11, 2011 Ms. Mary Beth Breslin Division of Corporate Finance United States Securities and Exchange Commission 100 F. Street N.W. Washington, D.C. 20549 Re: OxySure Systems, Inc. (the “Company”) Registration Statement on Form S-1 filed August 8, 2011 Registration No. 333-159402 Dear Ms. Br |
|
| August 11, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (AMENDMENT NO. 12 ) OxySure® Systems, Inc. Delaware 3841 71-0960725 (State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer Incorporation or Organization) Classification Code Number) Identification No.) OxySure Systems, Inc. 10880 John W. |
|
| August 9, 2011 |
Julian T. Ross, President OxySure Systems, Inc. 10880 John W. Elliott Drive, Suite 600 Frisco, TX 75034 August 9, 2011 Ms. Mary Beth Breslin Division of Corporate Finance United States Securities and Exchange Commission 100 F. Street N.W. Washington, D.C. 20549 Re: OxySure Systems, Inc. (the “Company”) Registration Statement on Form S-1 filed August 8, 2011 Registration No. 333-159402 Dear Ms. Bre |
|
| August 9, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (AMENDMENT NO. 11) OxySure® Systems, Inc. Delaware 3841 71-0960725 (State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer Incorporation or Organization) Classification Code Number) Identification No.) OxySure Systems, Inc. 10880 John W. E |
|
| August 9, 2011 |
FORM 8-A SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934 OxySure Systems, Inc. (Exact name of registrant as specified in its charter) Delaware (State of incorporation or organization) 71-0960725 (I.R.S. Employer Identification No.) 10880 John W. Elliot Drive, Suite 60 |
|
| August 8, 2011 |
OxySure® Systems, Inc. August 8, 2011 Mr. Geoffrey Kruczek Securities and Exchange Commission Washington, D.C. 20549 Re: OxySure Systems, Inc. Amendment No. 9 to Registration Statement on Form S-1/A Filed on July 25, 2011 File Number 333-159402 Dear Mr. Kruczek: We have received your comment letter dated August 4, 2011 (the “Comment Letter”) regarding Amendment No. 9 to our Registration Statement |
|
| August 8, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (AMENDMENT NO. 10) OxySure® Systems, Inc. Delaware 3841 71-0960725 (State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer Incorporation or Organization) Classification Code Number) Identification No.) OxySure Systems, Inc. 10880 John W. E |
|
| July 25, 2011 |
OxySure® Systems, Inc. July 25, 2011 Mr. Geoffrey Kruczek Securities and Exchange Commission Washington, D.C. 20549 Re: OxySure Systems, Inc. Amendment No. 8 to Registration Statement on Form S-1/A Filed on June 22, 2011 File Number 333-159402 Dear Mr. Kruczek: We have received your comment letter dated July 8, 2011 (the “Comment Letter”) regarding Amendment No. 8 to our Registration Statement on |
|
| July 25, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (AMENDMENT NO. 9) OxySure® Systems, Inc. Delaware 3841 71-0960725 (State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer Incorporation or Organization) Classification Code Number) Identification No.) OxySure Systems, Inc. 10880 John W. El |
|
| June 23, 2011 |
OxySure® Systems, Inc. June 22, 2011 Mr. Geoffrey Kruczek Securities and Exchange Commission Washington, D.C. 20549 Re: OxySure Systems, Inc. Amendment No. 7 to Registration Statement on Form S-1/A Filed on May 27, 2011 File Number 333-159402 Dear Mr. Kruczek: We have received your comment letter dated June 13, 2011 (the “Comment Letter”) regarding Amendment No. 7 to our Registration Statement on |
|
| June 22, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (AMENDMENT NO. 8 ) OxySure® Systems, Inc. Delaware 3841 71-0960725 (State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer Incorporation or Organization) Classification Code Number) Identification No.) OxySure Systems, Inc. 10880 John W. E |
|
| May 27, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (AMENDMENT NO. 7 ) OxySure? Systems, Inc. Delaware 3841 71-0960725 (State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer Incorporation or Organization) Classification Code Number) Identification No.) OxySure Systems, Inc. 10880 John W. E |
|
| May 27, 2011 |
SECOND MODIFICATION OF AGREEMENT Exhibit 10.29.3 SECOND MODIFICATION OF AGREEMENT WHEREAS, OxySure Systems, Inc. (?OxySure?) and Afritex Medical Products (Pty) Ltd. (?Afritex?) (?OxySure? and ?Afritex? jointly, the ?Parties?) entered into that certain Note Purchase Agreement (?Note?) dated 3/26/2010 in the principal amount of $270,000; and WHEREAS, The Parties have agreed that it is in their best interests to modify the terms of |
|
| May 27, 2011 |
OxySure® Systems, Inc. May 27, 2011 Mr. Geoffrey Kruczek Securities and Exchange Commission Washington, D.C. 20549 Re: OxySure Systems, Inc. Amendment No. 6 to Registration Statement on Form S-1/A Filed on February 11, 2011 File Number 333-159402 Dear Mr. Kruczek: We have received your comment letter dated February 28, 2011 (the “Comment Letter”) regarding Amendment No. 6 to our Registration State |
|
| May 27, 2011 |
Exhibit 10.15.1 March 4, 2011 Mr. Julian T. Ross Chairman & CEO OxySure® Systems, Inc. 10880 John W. Elliot Road, Suite 600 Frisco, TX 75034 Re: Master Lease Number 6906, Lease Schedule Numbers 01 through and including Number 11 (collectively the “Leases”) Lessee: OxySure® Systems, Inc. (“Oxysure”) Lessor: Vencore Solutions LLC (“Vencore”) Dear Mr. Ross: The intent of this letter is to reaffirm th |
|
| May 27, 2011 |
Exhibit 10.3.2 AMENDED AND RESTATED PERFORMANCE AGREEMENT Between FRISCO ECONOMIC DEVELOPMENT CORPORATION And OXYSURE SYSTEMS, INCORPORATED This Amended and Restated Performance Agreement (the “Agreement”) is made and entered into by and between the Frisco Economic Development Corporation, (the “FEDC”), a Texas corporation organized and existing under Chapter 501 and 504 of the Texas Local Governm |
|
| May 27, 2011 |
PROMISSORY NOTE $213,000.00 Frisco, Texas March 22, 2011 Exhibit 10.3.3 PROMISSORY NOTE $213,000.00 Frisco, Texas March 22, 2011 FOR VALUE RECEIVED, OXYSURE SYSTEMS, INCORPORATED, a Delaware corporation (hereinafter called "Maker"), promises to pay to the order of FRISCO ECONOMIC DEVELOPMENT CORPORATION, a Texas corporation (hereinafter sometimes called "Holder"), at 6801 Gaylord Parkway, Ste. 400, Frisco, TX 75034, or at such place as the Holder may fr |
|
| May 27, 2011 |
UNANIMOUS CONSENT OF DIRECTORS IN LIEU OF SPECIAL MEETING Exhibit 10.7.3 UNANIMOUS CONSENT OF DIRECTORS IN LIEU OF SPECIAL MEETING The undersigned, being all the members of the Board of Directors of OxySure Systems, Inc. (the "Company"), a Delaware corporation, do hereby waive any and all requirements for calling, giving notice of, and holding a Special Meeting of the Directors of the Company and do hereby consent pursuant to the provisions of Section 14 |
|
| May 27, 2011 |
[SIGNATURES TO FOLLOW ON NEXT PAGE] Exhibit 10.4.3 March 23, 2011 Julian T. Ross Chairman & CEO OxySure Systems, Inc. 10880 John W. Elliott Road Suite 600 Frisco, TX 75034 Re: Letter Agreement (this "Agreement") between SINACOLA COMMERCIAL PROPERTIES, LTD., a Texas limited partnership ("Landlord"), and OXYSURE SYSTEMS, INC., a Delaware corporation ("Tenant") Dear Julian: Landlord and Tenant have agreed to exchange certain considerat |
|
| March 28, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-54137 OxySure Systems, Inc. (Exact name of registrant as specified in i |
|
| February 11, 2011 |
PROMISSORY NOTE $110,000 December 31, 2010 Exhibit 10.36 PROMISSORY NOTE $110,000 December 31, 2010 OxySure Systems, Inc., a company organized under the laws of the state of Delaware ("Obligor", which term, as used herein, shall include any successor thereto), for value received, hereby executes and delivers this Promissory Note (“Note”) in favor of Sinacola Commercial Properties, Ltd. ("Holder"), an entity duly organized under the laws of |
|
| February 11, 2011 |
OxySure® Systems, Inc. February 11, 2011 Mr. Geoffrey Kruczek Securities and Exchange Commission Washington, D.C. 20549 Re: OxySure Systems, Inc. Amendment No. 5 to Registration Statement on Form S-1/A Filed on November 12, 2010 File Number 333-159402 Dear Mr. Kruczek: We have received your comment letter dated February 4, 2011 (the “Comment Letter”) regarding Amendment No. 5 to our Registration S |
|
| February 11, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (AMENDMENT NO. 6) OxySure® Systems, Inc. Delaware 3841 71-0960725 (State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer Incorporation or Organization) Classification Code Number) Identification No.) OxySure Systems, Inc. 10880 John W. El |
|
| February 11, 2011 |
PROMISSORY NOTE $110,715 December 31, 2010 Exhibit 10.37 PROMISSORY NOTE $110,715 December 31, 2010 OxySure Systems, Inc., a company organized under the laws of the state of Delaware ("Obligor", which term, as used herein, shall include any successor thereto), for value received, hereby executes and delivers this Promissory Note (“Note”) in favor of Sinacola Commercial Properties, Ltd. ("Holder"), an entity duly organized under the laws of |
|
| February 11, 2011 |
Exhibit 10.38 STOCK PURCHASE WARRANT NEITHER THIS WARRANT NOR ANY SECURITIES ON EXERCISE HEREOF HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF REGISTRATION UNDER SUCH ACT AND APPLICABLE LAWS, OR THE AVAILABILITY OF AN EXEMPTION FROM SUCH REGISTRATION, OR AN O |
|
| February 11, 2011 |
[SIGNATURES TO FOLLOW ON NEXT PAGE] Exhibit 10.35 December 15, 2010 Julian T. Ross Chairman & CEO OxySure Systems, Inc. 10880 John W. Elliott Road Suite 600 Frisco, TX 75034 Re: Letter Agreement (this "Agreement") between SINACOLA COMMERCIAL PROPERTIES, LTD., a Texas limited partnership ("Landlord"), and OXYSURE SYSTEMS, INC., a Delaware corporation ("Tenant") Dear Julian: Landlord and Tenant have agreed to exchange certain consider |
|
| January 13, 2011 |
AMENDMENT TO LICENSE AGREEMENT Exhibit 10.29.1 AMENDMENT TO LICENSE AGREEMENT THIS AMENDMENT TO THE LICENSE AGREEMENT (this “Amendment”) is entered into on December 16, 2010 by and between OxySure Systems, Inc., a Delaware corporation (the “Company”) and Afritex Medical Products (Pty) Ltd., a company incorporated under the laws of the Republic of South Africa (“Afritex”). The Company and Afritex are sometimes referred to herein |
|
| January 13, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ( AMENDMENT NO. 5 ) OxySure® Systems, Inc. Delaware 3841 71-0960725 (State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer Incorporation or Organization) Classification Code Number) Identification No.) OxySure Systems, Inc. 10880 John W. |
|
| January 13, 2011 |
OxySure® Systems, Inc. January 13, 2011 Mr. Geoffrey Kruczek Securities and Exchange Commission Washington, D.C. 20549 Re: OxySure Systems, Inc. Amendment No. 4 to Registration Statement on Form S-1/A Filed on November 12, 2010 File Number 333-159402 Dear Mr. Kruczek: We have received your comment letter dated November 26, 2010 (the “Comment Letter”) regarding Amendment No. 4 to our Registration S |
|
| January 13, 2011 |
Exhibit 10.29.2 MODIFICATION OF AGREEMENT WHEREAS, OxySure Systems, Inc. (“OxySure”) and Afritex Medical Products (Pty) Ltd. (“Afritex”) (“OxySure” and “Afritex” jointly, the “Parties”) entered into that certain Note Purchase Agreement (“Note”) dated 3/26/2010 in the principal amount of $270,000; and WHEREAS, The Parties have agreed that it is in their best interests to modify the terms of the Not |
|
| November 12, 2010 |
OxySure® Systems, Inc. November 12, 2010 Mr. Geoffrey Kruczek Securities and Exchange Commission Washington, D.C. 20549 Re: OxySure Systems, Inc. Amendment No. 3 to Registration Statement on Form S-1/A Filed on October 5, 2010 File Number 333-159402 Dear Mr. Kruczek: We have received your comment letter dated October 22, 2010 (the “Comment Letter”) regarding Amendment No. 3 to our Registration Sta |
|
| November 12, 2010 |
THE BLACKWING GROUP, LLC 18921G E VALLEY VIEW PARKWAY #325 INDEPENDENCE, MO 64055 EXHIBIT 16.1 THE BLACKWING GROUP, LLC 18921G E VALLEY VIEW PARKWAY #325 INDEPENDENCE, MO 64055 816-813-0098 November 10, 2010 Securities and Exchange Commission 100 F. Street, N.E. Washington, DC 20549 RE: OxySure Systems, Inc. We have read the statements that we understand OxySure Systems, Inc. (?OxySure?) will include under Item 11(i) of the Form S-1/A filing with the Securities and Exchange Com |
|
| November 12, 2010 |
EXHIBIT 10.34 Memorandum of Understanding (1) The parties to this MOU are OxySure Systems, Inc., including its affiliates and subsidiaries (collectively, “OxySure”) and CardiaTech Holland, BV, including its affiliates and subsidiaries (collectively, “CardiaTech”). (2) CardiaTech wishes to be a distributor of OxySure products (“OxySure Products”). OxySure wishes to be a distributor of CardiaTech pr |
|
| November 12, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (AMENDMENT NO. 4 ) OxySure® Systems, Inc. Delaware 3841 71-0960725 (State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer Incorporation or Organization) Classification Code Number) Identification No.) OxySure Systems, Inc. 10880 John W. E |
|
| October 5, 2010 |
EXHIBIT 10.32 Department of Veterans Affairs Office of Acquisition and Logistics National Acquisition Center P.O. Box 76 Hines, IL 60141 NOV 10, 2008 In Reply Refer To: Mr. Julian Ross OxySure Systems, Inc. 10880 John W. Elliott Road, Suite 600 Frisco, TX 75034 Dear Mr. Ross: Enclosed is a copy of your Federal Supply Schedule Contract V797P-4153b effective November 15, 2008 through November 14, 20 |
|
| October 5, 2010 |
Report of Independent Registered Public Accounting Firm EXHIBIT 15 Report of Independent Registered Public Accounting Firm To the Board of Directors and Stockholders of OxySure Systems, Inc. |
|
| October 5, 2010 |
THIRD MODIFICATION OF AGREEMENT EXHIBIT 10.5.2 THIRD MODIFICATION OF AGREEMENT WHEREAS, OxySure Systems, Inc. (“OxySure”) and Agave Resources, LLC. (“Agave”) (OxySure and Agave jointly, the “Parties”) entered into that certain Promissory Note (“Note”) dated 4/15/08 in the principal amount of $750,000; and WHEREAS, The Parties have agreed that it is in their best interests to modify the terms of the Note. NOW, WHEREFORE, FOR GOOD |
|
| October 5, 2010 |
OxySure® Systems, Inc. October 4, 2010 Mr. Geoffrey Kruczek Securities and Exchange Commission Washington, D.C. 20549 Re: OxySure Systems, Inc. Amendment No. 2 to Registration Statement on Form S-1/A Filed July 15, 2010 File Number 333-159402 Dear Mr. Kruczek: We have received your comment letter dated August 11, 2010 (the “Comment Letter”) regarding Amendment No. 2 to our Registration Statement o |
|
| October 5, 2010 |
ADDENDUM TO LOCK-UP AGREEMENTS EXHIBIT 10.12.1 ADDENDUM TO LOCK-UP AGREEMENTS THIS ADDENDUM TO LOCK-UP AGREEMENTS (this “Addendum”) is made and entered into effective as of September 8, 2010 by and between OxySure Systems, Inc., a Texas corporation (the “Company”) and all shareholders of the Company (the “Shareholder”). The Company and Shareholders are sometimes referred to herein individually as “Party” and collectively as the |
|
| October 5, 2010 |
OxySure Systems, Inc. VOTING STOCK OPTION PLAN As Amended and Restated July 19, 2004 EXHIBIT 10.10.1 OxySure Systems, Inc. VOTING STOCK OPTION PLAN As Amended and Restated July 19, 2004 Scope and Purpose of Plan The purpose of the Plan is to is to strengthen OxySure Systems, Inc. (the “Company”) and its affiliates, by providing to participating employees, consultants, advisors and directors added incentive for high levels of performance and for unusual efforts to increase the earn |
|
| October 5, 2010 |
EXHIBIT 3.7 OXYSURE SYSTEMS, INC. Second Amended Certificate of Designations Series A Convertible Preferred Stock Par Value $0.0005 per share Pursuant to Section 151 of the General Corporation Law of the State of Delaware The undersigned, Julian Ross, Chief Executive Officer of OxySure Systems, Inc., a Delaware corporation (hereinafter called the ?Corporation?), DOES HEREBY CERTIFY that the follow |
|
| October 5, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (AMENDMENT NO. 3 ) OxySure? Systems, Inc. Delaware 3841 71-0960725 (State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer Incorporation or Organization) Classification Code Number) Identification No.) OxySure Systems, Inc. 10880 John W. E |
|
| October 5, 2010 |
EXHIBIT 10.31 NOTE PURCHASE AGREEMENT This Agreement is made and entered into this 26th Day of March, 2010 by and between OxySure Systems, Inc., a Delaware Corporation (“OxySure” or the “Company”) and Afritex Medical Products (Pty) Ltd. (“Investor”). WITNESSETH: NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by the parties to this A |
|
| October 5, 2010 |
THIRD MODIFICATION OF AGREEMENT EXHIBIT 10.6.2 THIRD MODIFICATION OF AGREEMENT WHEREAS, OxySure Systems, Inc. (“OxySure”) and JTR Investments, Ltd. (“JTR”) (OxySure and JTR jointly, the “Parties”) entered into that certain Promissory Note (“Note”) dated 3/1/08 in the principal amount of $250,000; and WHEREAS, The Parties have agreed that it is in their best interests to modify the terms of the Note. NOW, WHEREFORE, FOR GOOD AND |
|
| October 5, 2010 |
THE BLACKWING GROUP, LLC 18921G E VALLEY VIEW PARKWAY #325 INDEPENDENCE, MO 64055 EXHIBIT 16.1 THE BLACKWING GROUP, LLC 18921G E VALLEY VIEW PARKWAY #325 INDEPENDENCE, MO 64055 816-813-0098 August 16, 2010 Securities and Exchange Commission 100 F. Street, N.E. Washington, DC 20549 RE: Oxysure Systems, Inc. We have read the statements that we understand Oxysure Systems, Inc. will include under Item 23.4 of the Form S-1/A filing. We agree with such statements made regarding our f |
|
| October 5, 2010 |
EXHIBIT 10.33 DISTRIBUTION AGREEMENT This agreement (together with its related exhibits, the “Agreement”) is made and executed this Day of , 2010, (the “Effective Date”) by and between OXYSURE SYSTEMS, INC. (“OxySure”), a Delaware corporation with its primary place of business located at 10880 John W. Elliott Road, Suite 600, Frisco, Texas, 75034 USA and (the “Distributor”), located at . OxySure a |
|
| October 5, 2010 |
ATTORNEY DOCKET NO PATENT APPLICATION ROSS 2864000 EXHIBIT 10.8.1 EXHIBIT A ATTORNEY DOCKET NO PATENT APPLICATION ROSS 2864000 METHOD AND APPARATUS FOR GENERATING OXYGEN BACKGROUND OF THE INVENTION Field of the Invention The invention relates generally to oxygen generation and, more particularly, to robust oxygen generation from a solid or liquid. Description of the Related Art Highly pure oxygen gas is used within a variety of applications. More |
|
| October 5, 2010 |
EXHIBIT 10.28.1 MODIFICATION OF AGREEMENT WHEREAS, OxySure Systems, Inc. (“OxySure”) and the TONY & JUDY ALCEDO FAMILY TRUST (“Alcedo”) (OxySure and Alcedo jointly, the “Parties”) entered into that certain Note Purchase Agreement (“Note”) dated 12/10/09 in the principal amount of $100,000; and WHEREAS, The Parties have agreed that it is in their best interests to modify the terms of the Note. NOW, |
|
| September 30, 2010 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(B) OR (G) OF THE SECURITIES EXCHANGE ACT OF 1934 OMB APPROVAL OMB Number: 3235-0056 Expires: October 31, 2011 Estimated average burden hours per response. . . 3.0 OxySure Systems, Inc. (Exact name of registrant as specified in its charter) Delaware 71-0960725 |
|
| July 15, 2010 |
[SIGNATURES TO FOLLOW ON NEXT PAGE] December 10, 2009 Julian T. Ross Chairman & CEO OxySure Systems, Inc. 10880 John W. Elliott Road Suite 600 Frisco, TX 75034 Re: Letter Agreement (this "Agreement") between SINACOLA COMMERCIAL PROPERTIES, LTD., a Texas limited partnership ("Landlord"), and OXYSURE SYSTEMS, INC., a Delaware corporation ("Tenant") Dear Julian: Landlord and Tenant have agreed to exchange certain consideration for cert |
|
| July 15, 2010 |
NOTE PURCHASE AGREEMENT This Agreement is made and entered into this 10th day of December, 2010 by and between OxySure Systems, Inc. |
|
| July 15, 2010 |
DISTRIBUTION AGREEMENT This Distribution Agreement (together with its related exhibits, the “Agreement”) is made and executed this 26th Day of March 2010 the “Effective Date”) by and between OXYSURE® SYSTEMS, INC. |
|
| July 15, 2010 |
AGREEMENT This Agreement (“Agreement”) is made and entered into on April 20, 2009 by and between OxySure Systems, Inc. |
|
| July 15, 2010 |
CANCELLATION AGREEMENT & MUTUAL RELEASE CANCELLATION AGREEMENT & MUTUAL RELEASE THE UNDERSIGNED parties hereby agree that that certain warrant purchase agreement (“Agreement”) dated April 20, 2009 between the parties be cancelled and the parties hereby release all of their right, title, and interest in and to said Agreement. |
|
| July 15, 2010 |
NOTE PURCHASE AGREEMENT This Agreement is made and entered into this 26th Day of March, 2010 by and between OxySure Systems, Inc. |
|
| July 15, 2010 |
LICENSE AGREEMENT This License Agreement ("Agreement") is established between Afritex Medical Products (Pty) Ltd. |
|
| July 15, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (AMENDMENT NO. 2) OxySure® Systems, Inc. Delaware 3841 71-0960725 (State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer Incorporation or Organization) Classification Code Number) Identification No.) OxySure Systems, Inc. 10880 John W. El |
|
| July 15, 2010 |
MODIFICATION OF AGREEMENT (THIRD MODIFICATION) MODIFICATION OF AGREEMENT (THIRD MODIFICATION) WHEREAS, OxySure Systems, Inc. (“OxySure”) and Julian T. Ross (“Ross”) (OxySure and Ross jointly, the “Parties”) entered into that certain Employment Agreement (“Agreement”) dated January 15, 2009, as amended, for the second time on June 23, 2009; and WHEREAS, The Parties have agreed that it is in their best interests to modify the terms of the Agreem |
|
| July 15, 2010 |
EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT, as amended (hereinafter referred to as the "Agreement") is made and entered into as of the 15th day of January, 2009 (“Effective Date”), by and between OXYSURE SYSTEMS, INC. |
|
| July 15, 2010 |
OxySure® Systems, Inc. July 15, 2010 Mr. Geoffrey Kruczek Securities and Exchange Commission Washington, D.C. 20549 Re: OxySure Systems, Inc. Registration Statement on Form S-1/A Filed August 12, 2009 File Number 333-189-402 Dear Mr. Kruczek: We have received your comment letter dated September 1, 2009 (the “Comment Letter”) regarding our Registration Statement on Form S-1/A filed on August 12, 20 |
